Anne Burger is a seasoned biotech executive with over 15 years of financial leadership experience, recently serving as CFO and interim CEO at CatalYm. She co-founded Breath Therapeutics, leading its sale to Zambon for up to €500M. Anne holds a Business Administration degree from Ludwig-Maximilians-University and has managed multiple successful company exits.
She was instrumental in two major biotech acquisitions: the sale of co-founded Breath Therapeutics to Zambon and Rigontecs sale to MSD, with combined potential deal values approaching €1 billion.
Read the full overview →They are naturally enthusiastic, so take their promise with a pinch of salt. They are not always early adopters but can be pursuaded by leveraging strong relationships. They excel at seeing the bigger picture, and the long-term impact of their decisions.
Anne has no verified education history
Influence (I) reflects the degree to which a person prefers to work by influencing or persuading others. Those scoring high tend to be people oriented, motivated by social recognition and building relationships.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.